Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma

PURPOSE: Stereotactic body radiotherapy (SBRT) takes advantage of low α/β ratio of prostate cancer to deliver a large dose in few fractions. We examined clinical outcomes of SBRT using CyberKnife for the treatment of low- and intermediate-risk prostate cancer. MATERIALS AND METHODS: This study was b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiat Oncol J
Hlavní autoři: Kim, Hun Jung, Phak, Jeong Hoon, Kim, Woo Chul
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society for Radiation Oncology 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5207371/
https://ncbi.nlm.nih.gov/pubmed/27306777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3857/roj.2015.01571
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky